Here, we demonstrated that miR-29c targeted the 3′UTR of DNMT3B and inhibited its expression, and that both miR-29c expression and DNMT3B expression were associated with the survival rate of patients with breast cancer. Here, DNMT3B is linked to breast carcinoma.